GB9603699D0 - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
GB9603699D0
GB9603699D0 GBGB9603699.1A GB9603699A GB9603699D0 GB 9603699 D0 GB9603699 D0 GB 9603699D0 GB 9603699 A GB9603699 A GB 9603699A GB 9603699 D0 GB9603699 D0 GB 9603699D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
ibuprofen
therapeutic composition
fever
bicarbonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9603699.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Priority to GBGB9603699.1A priority Critical patent/GB9603699D0/en
Publication of GB9603699D0 publication Critical patent/GB9603699D0/en
Priority to AU17937/97A priority patent/AU722991B2/en
Priority to PL97328465A priority patent/PL187383B1/pl
Priority to DE69730314T priority patent/DE69730314T2/de
Priority to PT97903352T priority patent/PT881899E/pt
Priority to CZ0261798A priority patent/CZ298371B6/cs
Priority to CN97193778A priority patent/CN1215989A/zh
Priority to HU9901454A priority patent/HUP9901454A3/hu
Priority to KR1019980706472A priority patent/KR19990087084A/ko
Priority to EP97903352A priority patent/EP0881899B1/en
Priority to UA98094870A priority patent/UA55407C2/uk
Priority to NZ331416A priority patent/NZ331416A/en
Priority to IL12580397A priority patent/IL125803A0/xx
Priority to RU98117388/14A priority patent/RU2182000C2/ru
Priority to CA002246344A priority patent/CA2246344C/en
Priority to DK97903352T priority patent/DK0881899T3/da
Priority to SK1142-98A priority patent/SK285032B6/sk
Priority to US09/125,114 priority patent/US20020034540A1/en
Priority to AT97903352T priority patent/ATE273696T1/de
Priority to JP9529808A priority patent/JP2000507922A/ja
Priority to ES97903352T priority patent/ES2227670T3/es
Priority to PCT/EP1997/000841 priority patent/WO1997030699A2/en
Priority to ZA9701446A priority patent/ZA971446B/xx
Priority to NO983825A priority patent/NO983825L/no
Priority to BG102744A priority patent/BG64165B1/bg
Priority to JP2008276306A priority patent/JP2009073847A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9603699.1A 1996-02-21 1996-02-21 Therapeutic composition Pending GB9603699D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition
PCT/EP1997/000841 WO1997030699A2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen
IL12580397A IL125803A0 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen
CA002246344A CA2246344C (en) 1996-02-21 1997-02-19 A solid non-effervescent compressed dosage form containing racemic ibuprofen
DE69730314T DE69730314T2 (de) 1996-02-21 1997-02-19 Dosierungsform von ibuprofen
PT97903352T PT881899E (pt) 1996-02-21 1997-02-19 Forma de dosagem de ibuprofeno
CZ0261798A CZ298371B6 (cs) 1996-02-21 1997-02-19 Dávkovací forma ibuprofenu a zpusob její prípravy
CN97193778A CN1215989A (zh) 1996-02-21 1997-02-19 布洛芬的剂型
HU9901454A HUP9901454A3 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen
KR1019980706472A KR19990087084A (ko) 1996-02-21 1997-02-19 이부프로펜 투여형
EP97903352A EP0881899B1 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen
UA98094870A UA55407C2 (uk) 1996-02-21 1997-02-19 Тверда нешипуча дозована форма ібупрофену, інгредієнт, який поліпшує здатність її до пресування, та спосіб одержання
NZ331416A NZ331416A (en) 1996-02-21 1997-02-19 Non-effervescent compressed solid dosage form of ibuprofen
AU17937/97A AU722991B2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen
RU98117388/14A RU2182000C2 (ru) 1996-02-21 1997-02-19 Дозированная форма ибупрофена
PL97328465A PL187383B1 (pl) 1996-02-21 1997-02-19 Stała niemusująca prasowana postać dawkowa zawierająca recemiczną ibuprofenową substancję leczniczą, zastosowanie, sposób wytwarzania stałej niemusującej postaci dawkowej, preparat stały i wielowarstwowy preparat stały
DK97903352T DK0881899T3 (da) 1996-02-21 1997-02-19 Ibuprofen-doseringsform
SK1142-98A SK285032B6 (sk) 1996-02-21 1997-02-19 Dávkovacie formy ibuprofénu
US09/125,114 US20020034540A1 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen
AT97903352T ATE273696T1 (de) 1996-02-21 1997-02-19 Dosierungsform von ibuprofen
JP9529808A JP2000507922A (ja) 1996-02-21 1997-02-19 イブプロフェンの剤型
ES97903352T ES2227670T3 (es) 1996-02-21 1997-02-19 Forma de dosificacion de ibuprofeno.
ZA9701446A ZA971446B (en) 1996-02-21 1997-02-20 Therapeutic composition.
NO983825A NO983825L (no) 1996-02-21 1998-08-20 Dosering av ibuprofen
BG102744A BG64165B1 (bg) 1996-02-21 1998-09-02 Дозирана лекарствена форма на ибупрофен
JP2008276306A JP2009073847A (ja) 1996-02-21 2008-10-28 イブプロフェンの剤型

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition

Publications (1)

Publication Number Publication Date
GB9603699D0 true GB9603699D0 (en) 1996-04-17

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9603699.1A Pending GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition

Country Status (25)

Country Link
US (1) US20020034540A1 (enExample)
EP (1) EP0881899B1 (enExample)
JP (2) JP2000507922A (enExample)
KR (1) KR19990087084A (enExample)
CN (1) CN1215989A (enExample)
AT (1) ATE273696T1 (enExample)
AU (1) AU722991B2 (enExample)
BG (1) BG64165B1 (enExample)
CA (1) CA2246344C (enExample)
CZ (1) CZ298371B6 (enExample)
DE (1) DE69730314T2 (enExample)
DK (1) DK0881899T3 (enExample)
ES (1) ES2227670T3 (enExample)
GB (1) GB9603699D0 (enExample)
HU (1) HUP9901454A3 (enExample)
IL (1) IL125803A0 (enExample)
NO (1) NO983825L (enExample)
NZ (1) NZ331416A (enExample)
PL (1) PL187383B1 (enExample)
PT (1) PT881899E (enExample)
RU (1) RU2182000C2 (enExample)
SK (1) SK285032B6 (enExample)
UA (1) UA55407C2 (enExample)
WO (1) WO1997030699A2 (enExample)
ZA (1) ZA971446B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
US20030008003A1 (en) * 2001-04-10 2003-01-09 Fahkreddin Jamali Compositions for enhanced absorption of NSAIDs
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
CA2510320C (en) * 2002-12-20 2012-10-09 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
NZ552208A (en) * 2004-06-29 2008-11-28 Nycomed Danmark Aps Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
KR101482922B1 (ko) * 2004-08-12 2015-01-15 레킷트 벵키저 헬스케어(유케이)리미티드 용융 압출에 의해 제조된, ｎｓａｉｄ와 당 알콜을 포함하는 과립
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CA2589079A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
PL1850834T3 (pl) * 2005-02-09 2015-03-31 Boehringer Ingelheim Int Tabletki powlekane zawierające lizynian ibuprofenu
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
WO2006100281A2 (en) 2005-03-22 2006-09-28 Losan Pharma Gmbh Solubilized ibuprofen
CA2622704A1 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20070521A7 (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
AU2007338843B2 (en) * 2006-12-20 2013-05-09 Teva Women's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
WO2009135946A1 (en) * 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2309988B1 (en) 2008-07-21 2015-11-25 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2323976A4 (en) * 2008-08-14 2014-07-02 Shasun Chemicals And Drugs Ltd ARYLALKYLCARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION THEREOF AND GALENIC FORMS
RU2715680C2 (ru) * 2009-06-22 2020-03-03 ВАЙЕТ ЭлЭлСи Таблетки ибупрофена натрия и способы изготовления фармацевтических композиций, включающих ибупрофен натрия
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
JP6304896B2 (ja) * 2013-07-30 2018-04-04 ライオン株式会社 錠剤
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
JP2017519015A (ja) 2014-07-02 2017-07-13 オブセヴァ エス．エー． Ｏｔ−ｒ活性に関する疾患を治療するための方法に有用な結晶質の（３ｚ，５ｓ）−５−（ヒドロキシメチル）−１−［（２’−メチル−１，１’−ビフェニル−４−イル）カルボニル］ピロリジン−３−オン о−メチルオキシム
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
AU8320387A (en) * 1986-10-22 1988-05-25 Upjohn Company, The Treatment of gingivitis with ibuprofen or flurbiprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
CA2102530C (en) * 1991-05-13 2003-07-29 Bernard J. Armitage Therapeutic agent
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel

Also Published As

Publication number Publication date
PL328465A1 (en) 1999-02-01
PL187383B1 (pl) 2004-06-30
CA2246344A1 (en) 1997-08-28
BG64165B1 (bg) 2004-03-31
DE69730314T2 (de) 2005-08-18
JP2009073847A (ja) 2009-04-09
PT881899E (pt) 2004-12-31
KR19990087084A (ko) 1999-12-15
US20020034540A1 (en) 2002-03-21
JP2000507922A (ja) 2000-06-27
RU2182000C2 (ru) 2002-05-10
IL125803A0 (en) 1999-04-11
AU1793797A (en) 1997-09-10
CA2246344C (en) 2009-01-20
SK285032B6 (sk) 2006-05-04
DK0881899T3 (da) 2004-12-20
ATE273696T1 (de) 2004-09-15
CZ261798A3 (cs) 1998-11-11
EP0881899A2 (en) 1998-12-09
CN1215989A (zh) 1999-05-05
NO983825D0 (no) 1998-08-20
HUP9901454A3 (en) 2001-04-28
AU722991B2 (en) 2000-08-17
SK114298A3 (en) 1999-01-11
ZA971446B (en) 1997-11-25
UA55407C2 (uk) 2003-04-15
WO1997030699A2 (en) 1997-08-28
WO1997030699A3 (en) 1997-10-09
EP0881899B1 (en) 2004-08-18
HUP9901454A2 (hu) 1999-08-30
BG102744A (bg) 1999-05-31
NO983825L (no) 1998-10-20
DE69730314D1 (de) 2004-09-23
ES2227670T3 (es) 2005-04-01
NZ331416A (en) 2000-02-28
CZ298371B6 (cs) 2007-09-12

Similar Documents

Publication Publication Date Title
GB9603699D0 (en) Therapeutic composition
US5782971B1 (en) Calcium phosphate cements comprising amorophous calcium phosphate
IL112518A0 (en) Thyroid hormone fast dispersing pharmaceutical composition
CA2265766A1 (en) Rapidly disintegrating pellets
AU4603789A (en) Hemostatic collagen paste composition
ES2046083A1 (es) Procedimiento para preparar composiciones de liberacion prolongada.
MD1663B2 (en) Composition and methods for human sexual activity modulation and impotency treatment
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ZA949309B (en) Composition for the production of therapeutic products in vivo
NZ514077A (en) Treatment of Α-galactosidase A deficiency
ES2033196A1 (es) Granulos diospersables de productos fungicidas.
CA2228295A1 (en) Cosmetic powder compositions having improved skin coverage
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
ES8303090A1 (es) Procedimiento para la obtencion de comprimidos medicionales de rapida disgregacion.
MY109531A (en) Effervescent antacid
NZ337418A (en) Paracetamol composition with improved rate of absorption
MY110014A (en) Psyllium-containing products.
CA2210321A1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
EP0237241A3 (en) Calcium supplement compressed tablets
EP0367056A3 (en) A granulating composition and method
GR3036470T3 (en) Process for preparing a clodronate preparation
ES2059260A1 (es) Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
JPS5344617A (en) Drug composition
MD566C2 (ro) Procedeu de preparare a materialului plastic sclerosuspendator din ţesutul osos
JPS5655305A (en) Material for repairing dental cavity